Kura Oncology, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KURA | AKTS | AVBP | BBOT | ORIC | SNDX | |
|---|---|---|---|---|---|---|
| Market cap | 924.75M | 964.44M | 811.61M | 261.37M | 1.22B | 1.48B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.4 | -8.1 | -4.2 | -1.2 | -7.1 | -19.4 |
| Price/book | 19.1 | 2.0 | 2.2 | 0.8 | 3.2 | 97.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +6.75% | −22.59% | −17.70% | −71.12% | −13.80% | +11.78% |
| Today | −1.93% | −4.46% | −1.61% | −1.51% | −1.50% | −2.59% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KURA news ›Kura Oncology, Inc. (NASDAQ:KURA) Stock Has Average Price Target of $25.69
Posted by Defense World Staff on Oct 11th, 2026 Check Out Our Latest Research Report on Kura Oncology Kura Oncology, Inc is a biopharmaceutical company focused on developing precision medicines for the treatment of cancer. The company uses…
Caspian Therapeutics and Kura Oncology to Host Investor Webcast on Caspian Formation and KO-7246 Data from EASD Meeting
Caspian Therapeutics and Kura Oncology will host an investor webcast on October 13 to discuss recent developments and data. The investor webcast will take place on Tuesday, October 13 at 4:30 p.m. ET. The replay will be available on…
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
Kura Oncology (Nasdaq: KURA) and Caspian Therapeutics will host an investor webcast on October 13, 2026, at 4:30 p.m. ET. Management will discuss Caspian’s formation and review KO-7246 data featured in an oral presentation at the 62nd…
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Manila Times Each stock option has an exercise price equal to $10.65 per share, the closing price of the Company’s common stock on October 1, 2026, and will vest over four years, with 25% of the underlying shares vesting on the…
A stock award brings Robert Cascella's direct KORU Medical (KRMD) holdings to 103,274 shares.
Lumentum Announces Speaker Lineup at 2026 OCP Global Summit Following the award, the director reported direct holdings of 103,274 KORU Medical Systems common shares. Sentiment and the balance of points Rhea-AI Sentiment reads the wording…
Kura Oncology COO Kathleen Ford sells $111,930 in company stock By Investing.com
Kura Oncology COO Kathleen Ford sells $111,930 in company stock Investing.com
Kura Oncology (NASDAQ:KURA) Insider Sells $165,872.50 in Stock
Posted by Tristan Rich on Sep 29th, 2026 Read Our Latest Stock Report on Kura Oncology Here are the key news stories impacting Kura Oncology this week: Kura Oncology, Inc is a biopharmaceutical company focused on developing precision…
Caspian Therapeutics, Inc. And Kura Oncology, Inc. Unveil KO-7246 At EASD As A Potential Best-In-Class Menin Inhibitor For Diabetes
marketscreener.com and Kura Oncology, Inc announced comprehensive preclinical data supporting KO-7246 as a potential best-in-class menin inhibitor for diabetes KO-7246 regenerated functional Ã-cell mass, demonstrated durable glycemic…
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
CEO Thane Wettig’s Sept. 15, 4:00 PM ET presentation will stream live and replay for 90 days via webcast. Kyntra Bio (KYNB) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York from September 14–16,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net2
-
defenseworld.net1
-
investing.com1
-
manilatimes.net1
-
quiverquant.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.